You might be interested in
Health & Biotech
Digital prescription: ASX stocks transforming healthcare sector
Health & Biotech
Dr Boreham's Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Health & Biotech
Health & Biotech
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim interviews Kate Quirke, Group Managing Director of Alcidion (ASX:ALC).
The company operates in the burgeoning field of health infomatics, which takes patient data and enhances it to improve the standard of care.
Alcidion’s platform helps hospitals to improve the flow of patient information, which in turn prevents complications and mortalities resulting from incorrect and incomplete paperwork.
In essence, Alcidion helps remove the doctors and nurses clipboards and replaces them with real time digital monitoring.
Tune in to hear the pair discuss the death of the doctor’s clipboard, how Alcidion’s infomatics saves lives and why it’s best to bide your time with a US entrance.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!